1. Home
  2. THAR vs VERO Comparison

THAR vs VERO Comparison

Compare THAR & VERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tharimmune Inc.

THAR

Tharimmune Inc.

HOLD

Current Price

$3.01

Market Cap

90.8M

Sector

Health Care

ML Signal

HOLD

Logo Venus Concept Inc.

VERO

Venus Concept Inc.

HOLD

Current Price

$1.48

Market Cap

4.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
THAR
VERO
Founded
2017
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
90.8M
4.0M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
THAR
VERO
Price
$3.01
$1.48
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
458.0K
2.7M
Earning Date
11-12-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$58,876,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$10.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.95
$1.45
52 Week High
$9.08
$14.50

Technical Indicators

Market Signals
Indicator
THAR
VERO
Relative Strength Index (RSI) 63.20 37.02
Support Level $2.20 $1.63
Resistance Level $3.20 $1.78
Average True Range (ATR) 0.21 0.22
MACD 0.09 -0.03
Stochastic Oscillator 81.00 2.13

Price Performance

Historical Comparison
THAR
VERO

About THAR Tharimmune Inc.

Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.

About VERO Venus Concept Inc.

Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.

Share on Social Networks: